You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 21 No. 4, October 1969 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (10)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Dawson's Encephalitis With 5-Bromo-2'-Deoxyuridine

Double-Blind Study

John M. Freeman, MD

Arch Neurol. 1969;21(4):431-434.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

DAWSON'S encephalitis is a progressive degenerative disease of the central nervous system secondary to a chronic viral infection. Histologic, electron microscopic, immunologic, and immunofluorescent studies indicate that the etiologic agent in this disease is the rubeola virus. In addition, the rubeola virus has been cultured from brain tissue obtained at cerebral biopsy from several patients. As a chronic progressive infection of the brain, this disease might be susceptible to antiviral chemotherapy. Preliminary trials suggested that 5-bromo-2'-deoxyuridine (BUDR) might alter the course of the disease.1,2 To further evaluate this preliminary data, as well as to acquire detailed information regarding the course of Dawson's encephalitis, a double-blind study was undertaken using BUDR and placebo.

Materials and Methods

Patients were included in the study if all the following characteristics of Dawson's encephalitis were manifest2: (1) intellectual or personality change; (2) myoclonic jerks; (3) periodic bursts of slow wave or synchronous . . . [Full Text PDF of this Article]


Author Affiliations

Stanford, Calif

From the Department of Pediatrics and Human Development, Stanford University School of Medicine, Stanford, Calif. Dr. Freeman is now with the Department of Neurology, Johns Hopkins Hospital, Baltimore.


Footnotes

Submitted for publication May 24, 1969; accepted June 24.

Reprint requests to the Department of Neurology, Johns Hopkins Hospital, Baltimore 21205.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1969 American Medical Association. All Rights Reserved.